Cefetamet

DB13504

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 397.42
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

796 Data
Probenecid The serum concentration of Cefetamet can be increased when it is combined with Probenecid.
Foscarnet The risk or severity of nephrotoxicity can be increased when Cefetamet is combined with Foscarnet.
Mannitol The risk or severity of nephrotoxicity can be increased when Mannitol is combined with Cefetamet.
Tenofovir disoproxil Cefetamet may increase the nephrotoxic activities of Tenofovir disoproxil.
Tenofovir alafenamide Cefetamet may increase the nephrotoxic activities of Tenofovir alafenamide.
Tenofovir Cefetamet may increase the nephrotoxic activities of Tenofovir.
Picosulfuric acid The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Cefetamet.
Cyclosporine The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Cefetamet.
Icosapent The risk or severity of nephrotoxicity can be increased when Icosapent is combined with Cefetamet.
Cefotiam The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Cefetamet.
Mesalazine The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefetamet.
Cefmenoxime The risk or severity of nephrotoxicity can be increased when Cefmenoxime is combined with Cefetamet.
Cefmetazole The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Cefetamet.
Indomethacin The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Cefetamet.
Triamterene The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cefetamet.
Cefpiramide The risk or severity of nephrotoxicity can be increased when Cefpiramide is combined with Cefetamet.
Loracarbef The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Cefetamet.
Cefalotin The risk or severity of nephrotoxicity can be increased when Cefalotin is combined with Cefetamet.
Nabumetone The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Cefetamet.
Ketorolac The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Cefetamet.
Tenoxicam The risk or severity of nephrotoxicity can be increased when Tenoxicam is combined with Cefetamet.
Celecoxib The risk or severity of nephrotoxicity can be increased when Celecoxib is combined with Cefetamet.
Cefotaxime The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Cefetamet.
Tolmetin The risk or severity of nephrotoxicity can be increased when Tolmetin is combined with Cefetamet.
Rofecoxib The risk or severity of nephrotoxicity can be increased when Rofecoxib is combined with Cefetamet.
Fenoprofen The risk or severity of nephrotoxicity can be increased when Fenoprofen is combined with Cefetamet.
Valdecoxib The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Cefetamet.
Diclofenac The risk or severity of nephrotoxicity can be increased when Diclofenac is combined with Cefetamet.
Sulindac The risk or severity of nephrotoxicity can be increased when Sulindac is combined with Cefetamet.
Bacitracin The risk or severity of nephrotoxicity can be increased when Bacitracin is combined with Cefetamet.
Amphotericin B The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefetamet.
Cephaloglycin The risk or severity of nephrotoxicity can be increased when Cephaloglycin is combined with Cefetamet.
Adefovir dipivoxil The risk or severity of nephrotoxicity can be increased when Adefovir dipivoxil is combined with Cefetamet.
Pentamidine The risk or severity of nephrotoxicity can be increased when Pentamidine is combined with Cefetamet.
Mefenamic acid The risk or severity of nephrotoxicity can be increased when Mefenamic acid is combined with Cefetamet.
Naproxen The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Cefetamet.
Sulfasalazine The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Cefetamet.
Phenylbutazone The risk or severity of nephrotoxicity can be increased when Phenylbutazone is combined with Cefetamet.
Meloxicam The risk or severity of methemoglobinemia can be increased when Cefetamet is combined with Meloxicam.
Carprofen The risk or severity of nephrotoxicity can be increased when Carprofen is combined with Cefetamet.
Tacrolimus The risk or severity of nephrotoxicity can be increased when Tacrolimus is combined with Cefetamet.
Etacrynic acid The risk or severity of nephrotoxicity can be increased when Etacrynic acid is combined with Cefetamet.
Ceforanide The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Cefetamet.
Salicylic acid The risk or severity of nephrotoxicity can be increased when Salicylic acid is combined with Cefetamet.
Acetylsalicylic acid The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefetamet.
Hydrochlorothiazide The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Cefetamet.
Balsalazide The risk or severity of nephrotoxicity can be increased when Balsalazide is combined with Cefetamet.
Cefditoren The risk or severity of nephrotoxicity can be increased when Cefditoren is combined with Cefetamet.
Atazanavir The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Cefetamet.
Colistimethate The risk or severity of nephrotoxicity can be increased when Colistimethate is combined with Cefetamet.
Cefuroxime The risk or severity of nephrotoxicity can be increased when Cefuroxime is combined with Cefetamet.
Cefapirin The risk or severity of nephrotoxicity can be increased when Cefapirin is combined with Cefetamet.
Cefprozil The risk or severity of nephrotoxicity can be increased when Cefprozil is combined with Cefetamet.
Olsalazine The risk or severity of nephrotoxicity can be increased when Cefetamet is combined with Olsalazine.
Lumiracoxib The risk or severity of nephrotoxicity can be increased when Lumiracoxib is combined with Cefetamet.
Cefamandole The risk or severity of nephrotoxicity can be increased when Cefamandole is combined with Cefetamet.
Cefazolin The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Cefetamet.
Cefonicid The risk or severity of nephrotoxicity can be increased when Cefonicid is combined with Cefetamet.
Cefoperazone The risk or severity of nephrotoxicity can be increased when Cefoperazone is combined with Cefetamet.
Cefoxitin The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Cefetamet.
Ceftizoxime The risk or severity of nephrotoxicity can be increased when Ceftizoxime is combined with Cefetamet.
Magnesium salicylate The risk or severity of nephrotoxicity can be increased when Magnesium salicylate is combined with Cefetamet.
Salsalate The risk or severity of nephrotoxicity can be increased when Salsalate is combined with Cefetamet.
Choline magnesium trisalicylate The risk or severity of nephrotoxicity can be increased when Choline magnesium trisalicylate is combined with Cefetamet.
Cefepime The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Cefetamet.
Cefacetrile The risk or severity of nephrotoxicity can be increased when Cefacetrile is combined with Cefetamet.
Cefpodoxime The risk or severity of nephrotoxicity can be increased when Cefpodoxime is combined with Cefetamet.
Antrafenine The risk or severity of nephrotoxicity can be increased when Antrafenine is combined with Cefetamet.
Aminophenazone The risk or severity of nephrotoxicity can be increased when Aminophenazone is combined with Cefetamet.
Antipyrine The risk or severity of nephrotoxicity can be increased when Antipyrine is combined with Cefetamet.
Tiaprofenic acid The risk or severity of nephrotoxicity can be increased when Tiaprofenic acid is combined with Cefetamet.
Lopinavir The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Cefetamet.
Etoricoxib The risk or severity of nephrotoxicity can be increased when Etoricoxib is combined with Cefetamet.
Hydrolyzed Cephalothin The risk or severity of nephrotoxicity can be increased when Hydrolyzed Cephalothin is combined with Cefetamet.
Cephalothin Group The risk or severity of nephrotoxicity can be increased when Cephalothin Group is combined with Cefetamet.
Oxyphenbutazone The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Cefetamet.
Latamoxef The risk or severity of nephrotoxicity can be increased when Latamoxef is combined with Cefetamet.
Nimesulide The risk or severity of nephrotoxicity can be increased when Nimesulide is combined with Cefetamet.
Benoxaprofen The risk or severity of nephrotoxicity can be increased when Benoxaprofen is combined with Cefetamet.
Metamizole The risk or severity of nephrotoxicity can be increased when Metamizole is combined with Cefetamet.
Zomepirac The risk or severity of nephrotoxicity can be increased when Zomepirac is combined with Cefetamet.
Ceftobiprole The risk or severity of nephrotoxicity can be increased when Ceftobiprole is combined with Cefetamet.
Cimicoxib The risk or severity of nephrotoxicity can be increased when Cimicoxib is combined with Cefetamet.
Ceftaroline fosamil The risk or severity of nephrotoxicity can be increased when Ceftaroline fosamil is combined with Cefetamet.
Lornoxicam The risk or severity of nephrotoxicity can be increased when Lornoxicam is combined with Cefetamet.
Zaltoprofen The risk or severity of nephrotoxicity can be increased when Zaltoprofen is combined with Cefetamet.
Azapropazone The risk or severity of nephrotoxicity can be increased when Azapropazone is combined with Cefetamet.
Parecoxib The risk or severity of nephrotoxicity can be increased when Parecoxib is combined with Cefetamet.
Salicylamide The risk or severity of nephrotoxicity can be increased when Salicylamide is combined with Cefetamet.
Kebuzone The risk or severity of nephrotoxicity can be increased when Kebuzone is combined with Cefetamet.
Isoxicam The risk or severity of nephrotoxicity can be increased when Isoxicam is combined with Cefetamet.
Indoprofen The risk or severity of nephrotoxicity can be increased when Indoprofen is combined with Cefetamet.
Ibuproxam The risk or severity of nephrotoxicity can be increased when Ibuproxam is combined with Cefetamet.
Floctafenine The risk or severity of nephrotoxicity can be increased when Floctafenine is combined with Cefetamet.
Fenbufen The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Cefetamet.
Etofenamate The risk or severity of nephrotoxicity can be increased when Etofenamate is combined with Cefetamet.
Epirizole The risk or severity of nephrotoxicity can be increased when Epirizole is combined with Cefetamet.
Cefaloridine The risk or severity of nephrotoxicity can be increased when Cefaloridine is combined with Cefetamet.
Cefminox The risk or severity of nephrotoxicity can be increased when Cefminox is combined with Cefetamet.
Dexibuprofen The risk or severity of nephrotoxicity can be increased when Dexibuprofen is combined with Cefetamet.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul